← Back to Search

Other

Oxygen for Coronavirus

Phase 2 & 3
Waitlist Available
Led By Sylvain Boet, MD, PhD
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured on day 28
Awards & highlights

Study Summary

This study is evaluating whether hyperbaric oxygen therapy can improve outcomes for COVID-19 patients who are admitted to hospital to receive extra oxygen.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured on day 28
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured on day 28 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
7-level COVID Ordinal Outcome Scale
Daily oxygen flow values required to obtain saturation values ≥90%
Days on invasive mechanical ventilation or high flow oxygenation
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: HBOTExperimental Treatment1 Intervention
These patients will receive hyperbaric oxygen therapy (HBOT) in addition to usual treatment for COVID-19. HBOT sessions will be 75 minutes in length at a pressure of 2.0 ATA.
Group II: ControlActive Control1 Intervention
These patients will receive usual treatment for COVID-19, including oxygenation at normal atmospheric pressure (normobaric oxygenation).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oxygen
2013
Completed Phase 4
~12430

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
561 Previous Clinical Trials
2,785,457 Total Patients Enrolled
Climate FoundationUNKNOWN
Sylvain Boet, MD, PhDPrincipal InvestigatorThe Ottawa Hospital
2 Previous Clinical Trials
225 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients
2021. "Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04500626.
All > Covid
~58 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top